InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by MCENANY PATRICK J, Chairman & CEO. Insider active across 1 companies, notably Catalyst Pharmaceuticals, INC.. Aggregated, 6 disclosures have been recorded. The latest transaction was disclosed on 20 August 2021 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
30,833 shares
Common Stock, par value $0.001 per share
SEC:0001161697-21-000565·
30,833 shares
Common Stock, par value $0.001 per share
SEC:0001161697-21-000565:0·
€213,76180,000 shares@ €2.6720.0056% mcap44.6% of flow
Common stock, par value $0.001 per share
SEC:0001161697-21-000406·
€213,76180,000 shares@ €2.6720.0056% mcap22.3% of flow
Common stock, par value $0.001 per share
SEC:0001161697-21-000406:0·
€265,843100,000 shares@ €2.65840.0070% mcap55.4% of flow
Common stock, par value $0.001 per share
SEC:0001161697-21-000387·
€265,843100,000 shares@ €2.65840.0070% mcap27.7% of flow
Common stock, par value $0.001 per share
SEC:0001161697-21-000387:0·
6 of 6 declarations
About MCENANY PATRICK J
Patrick J. McEnany is the President and CEO of Catalyst Pharmaceuticals, Inc., a biopharmaceutical company. In this role, he is responsible for the strategic direction of the company and the management of its operations. With extensive experience in the biopharmaceutical sector, he plays a key role in developing new treatments and driving innovation.
